Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1

Status

Completed 6Recruiting 5Unknown 4Active not recruiting 2Terminated 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 17Gastrointestinal 8Thoracic 7Lymphoid 7Other hematologic neoplasm 6Genitourinary 6Tumor-Agnostic 5Gynecologic 3Other 2Head & Neck 2Dermatologic 2CNS 2Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Neoplasms 5

Interventions

pembrolizumab 26Specimen Handling 17Blood Specimen Collection 17Biopsy 16Magnetic Resonance Spectroscopy 15atezolizumab 11Surveys and Questionnaires 11Bevacizumab 9Radiotherapy 8Radiosurgery 8Nivolumab 8Fluorouracil 8Standard of Care 7Paclitaxel 7Irinotecan 7Gemcitabine 7Cisplatin 7olaparib 6durvalumab 6Palliative Care 6Oxaliplatin 6Leucovorin 6Cyclophosphamide 6Carboplatin 6Capecitabine 6alectinib 5abemaciclib 5Trastuzumab 5Interviews as Topic 5Exercise 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Exercise × Tumor-Agnostic × Clear all
NCT05539794 2026-06-01

EXERCADOL

Universidad Europea de Madrid

Phase NA Recruiting
136 enrolled
Tumor-Agnostic

Neoplasms

NCT05912257 2026-05-20

NOSH

VA Office of Research and Development

Phase NA Recruiting
188 enrolled
Tumor-Agnostic

Neoplasms

NCT06323707 2025-03-12

IMPACT

McMaster University

Phase 2 Recruiting
129 enrolled
Tumor-Agnostic

Neoplasms

NCT04956133 2025-03-07

IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

University of Calgary

Phase NA Recruiting
250 enrolled
Tumor-Agnostic

Neoplasms

NCT03599843 2025-02-17

ACCESS

Nova Scotia Health Authority

Phase NA Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡